Eli Lilly (LLY) Intangibles (2016 - 2025)
Historic Intangibles for Eli Lilly (LLY) over the last 14 years, with Q4 2025 value amounting to $6.5 billion.
- Eli Lilly's Intangibles rose 575.74% to $6.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.5 billion, marking a year-over-year increase of 575.74%. This contributed to the annual value of $6.5 billion for FY2025, which is 575.74% up from last year.
- Per Eli Lilly's latest filing, its Intangibles stood at $6.5 billion for Q4 2025, which was up 575.74% from $6.4 billion recorded in Q3 2025.
- In the past 5 years, Eli Lilly's Intangibles registered a high of $8.1 billion during Q1 2021, and its lowest value of $5.9 billion during Q2 2025.
- Its 5-year average for Intangibles is $7.0 billion, with a median of $6.9 billion in 2023.
- Over the last 5 years, Eli Lilly's Intangibles had its largest YoY gain of 575.74% in 2025, and its largest YoY loss of 1109.11% in 2025.
- Quarter analysis of 5 years shows Eli Lilly's Intangibles stood at $7.7 billion in 2021, then decreased by 6.31% to $7.2 billion in 2022, then fell by 4.16% to $6.9 billion in 2023, then decreased by 10.72% to $6.2 billion in 2024, then increased by 5.76% to $6.5 billion in 2025.
- Its Intangibles was $6.5 billion in Q4 2025, compared to $6.4 billion in Q3 2025 and $5.9 billion in Q2 2025.